<DOC>
	<DOCNO>NCT01783340</DOCNO>
	<brief_summary>This study ass superior protective immunity combination chloroquine azithromycin prophylaxis Chemoprophylaxis Sporozoites ( CPS ) immunization versus standard chloroquine prophylactic regimen .</brief_summary>
	<brief_title>Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Chloroquine/Azithromycin Prophylaxis</brief_title>
	<detailed_description>This study assess superiority protective immunity combination chloroquine azithromycin prophylaxis Chemoprophylaxis Sporozoites ( CPS ) immunization versus standard chloroquine prophylactic regimen .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Age ≥ 18 ≤ 35 year healthy volunteer ( male female ) 2 . Good health base history clinical examination 3 . Negative pregnancy serum test 4 . For female sexually active : use adequate contraception ( incl . condom use ) 5 . Signing informed consent form , thereby demonstrate understand meaning procedure study 6 . Agreement inform general practitioner sign request release medical information concern contraindication participation study 7 . Willingness undergo Pf control infection mosquito bite 8 . Agreement stay hotel room close trial centre part study ( Day 7 till day 15 challenge ) 9 . Reachable ( 24/7 ) mobile phone whole study period 10 . Available attend study visit 11 . Agreement refrain blood donation purpose , whole study period 12 . Willingness undergo HIV , hepatitis B hepatitis C test 13 . Negative urine toxicology screen test screen visit day challenge 14 . Willingness take prophylactic regime chloroquine chloroquine/azithromycin combination curative regimen Malarone® challenge . 1 . History malaria 2 . Plans travel malaria endemic area study period 3 . Plans travel outside Netherlands challenge period 4 . History stay malaria endemic area 6 month 5 . Previous participation malaria vaccine study and/or positive serology Pf 6 . Symptoms , physical sign laboratory value suggestive systemic disorder include renal , hepatic , cardiovascular , pulmonary , skin , immunodeficiency , psychiatric , condition could interfere interpretation study result compromise health volunteer 7 . History diabetes mellitus cancer ( except basal cell carcinoma skin ) 8 . History arrhythmia prolong QTinterval 9 . Positive family history 1st 2nd degree relative cardiac event &lt; 50 year old 10 . An estimate , ten year risk fatal cardiovascular disease ≥5 % , estimate Systematic Coronary Risk Evaluation ( SCORE ) system 11 . Clinically significant abnormality electrocardiogram ( ECG ) screen 12 . Body Mass Index ( BMI ) 18 30 kg/m2 13 . Any clinically significant deviation normal range biochemistry haematology blood test urine analysis 14 . Positive HIV , HBV HCV test 15 . Participation clinical study within 30 day prior onset study 16 . Enrolment clinical study study period 17 . Pregnancy lactation woman 18 . Volunteers unable give write informed consent 19 . Volunteers unable closely follow social , geographic psychological reason 20 . History ( soft ) drug alcohol abuse interfere normal social function 21 . A history treatment psychiatric disease 22 . A history epileptic insult volunteer 23 . Contraindications use Malarone® , chloroquine azithromycin . This include hypersensitivity treatment take volunteer interferes mention study drug . 24 . The use chronic immunosuppressive drug , antibiotic , immune modifying drug within three month study onset ( topical corticosteroid oral antihistaminic allow ) study period 25 . Any confirmed suspected immunosuppressive immunodeficient condition , include ( functional ) asplenia 26 . Coworkers trainees department Medical Microbiology , Parasitology , Internal Medicine Leiden University Medical Centre 27 . A history sickle cell anaemia , sickle cell trait , thalassemia , thalassemia trait G6PD deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Malaria</keyword>
	<keyword>P falciparum</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Immunization</keyword>
</DOC>